Annual report
4530.TEDINET S100QTXW
Period2022-03-01 → 2023-02-28
Filed2023-05-26
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 158
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥128.3bn | 2022-03-01 → 2023-02-28 | Cons. | Net sales |
| Revenue | ¥120.2bn | 2021-03-01 → 2022-02-28 | Cons. | Net sales |
| Revenue | ¥114.5bn | 2020-03-01 → 2021-02-28d | Cons. | Net sales (5-year summary) |
| Revenue | ¥141.0bn | 2019-03-01 → 2020-02-29d | Cons. | Net sales (5-year summary) |
| Revenue | ¥143.4bn | 2018-03-01 → 2019-02-28d | Cons. | Net sales (5-year summary) |
| Operating income | ¥11.6bn | 2022-03-01 → 2023-02-28 | Cons. | Operating income |
| Operating income | ¥9.3bn | 2021-03-01 → 2022-02-28 | Cons. | Operating income |
| Ordinary income | ¥16.1bn | 2022-03-01 → 2023-02-28 | Cons. | Ordinary income |
| Ordinary income | ¥12.6bn | 2021-03-01 → 2022-02-28 | Cons. | Ordinary income |
| Ordinary income | ¥11.8bn | 2020-03-01 → 2021-02-28d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥25.6bn | 2019-03-01 → 2020-02-29d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥24.6bn | 2018-03-01 → 2019-02-28d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥16.1bn | 2022-03-01 → 2023-02-28 | Cons. | Income before income taxes |
| Profit before tax | ¥13.0bn | 2021-03-01 → 2022-02-28 | Cons. | Income before income taxes |
| Net income (owners) | ¥11.7bn | 2022-03-01 → 2023-02-28 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥9.7bn | 2021-03-01 → 2022-02-28 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥9.3bn | 2020-03-01 → 2021-02-28d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥18.7bn | 2019-03-01 → 2020-02-29d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥19.2bn | 2018-03-01 → 2019-02-28d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥12.1bn | 2022-03-01 → 2023-02-28 | Cons. | Profit loss |
| Net income | ¥9.9bn | 2021-03-01 → 2022-02-28 | Cons. | Profit loss |
| Total assets | ¥313.9bn | at 2023-02-28 | Cons. | Assets |
| Total assets | ¥302.9bn | at 2022-02-28 | Cons. | Assets |
| Total assets | ¥299.9bn | at 2021-02-28d | Cons. | Total assets (5-year summary) |
| Total assets | ¥307.4bn | at 2020-02-29d | Cons. | Total assets (5-year summary) |
| Total assets | ¥295.8bn | at 2019-02-28d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥55.5bn | at 2023-02-28 | Cons. | Liabilities |
| Total liabilities | ¥48.0bn | at 2022-02-28 | Cons. | Liabilities |
| Net assets / equity | ¥258.4bn | at 2023-02-28 | Cons. | Net assets |
| Net assets / equity | ¥254.9bn | at 2022-02-28 | Cons. | Net assets |
| Net assets / equity | ¥253.8bn | at 2021-02-28d | Cons. | Net assets |
| Net assets / equity | ¥250.7bn | at 2020-02-29d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥248.6bn | at 2019-02-28d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥122.2bn | at 2023-02-28 | Cons. | Cash and deposits |
| Cash and deposits | ¥129.3bn | at 2022-02-28 | Cons. | Cash and deposits |
| Cash & equivalents | ¥65.4bn | at 2023-02-28 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥86.2bn | at 2022-02-28 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥91.4bn | at 2021-02-28d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥87.0bn | at 2020-02-29d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥88.8bn | at 2019-02-28d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥12.7bn | 2022-03-01 → 2023-02-28 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥19.2bn | 2021-03-01 → 2022-02-28 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥5.3bn | 2020-03-01 → 2021-02-28d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥27.4bn | 2019-03-01 → 2020-02-29d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥15.8bn | 2018-03-01 → 2019-02-28d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥23.9bn | 2022-03-01 → 2023-02-28 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥13.1bn | 2021-03-01 → 2022-02-28 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥7.8bn | 2020-03-01 → 2021-02-28d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥17.2bn | 2019-03-01 → 2020-02-29d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥39.3bn | 2018-03-01 → 2019-02-28d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥14.7bn | 2022-03-01 → 2023-02-28 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥15.2bn | 2021-03-01 → 2022-02-28 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥7.2bn | 2020-03-01 → 2021-02-28d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥11.7bn | 2019-03-01 → 2020-02-29d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥13.3bn | 2018-03-01 → 2019-02-28d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥148.01 | 2022-03-01 → 2023-02-28 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥118.92 | 2021-03-01 → 2022-02-28 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥113.22 | 2020-03-01 → 2021-02-28d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥227.58 | 2019-03-01 → 2020-02-29d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥230.08 | 2018-03-01 → 2019-02-28d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥147.88 | 2022-03-01 → 2023-02-28 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥118.84 | 2021-03-01 → 2022-02-28 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥113.11 | 2020-03-01 → 2021-02-28d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥227.3 | 2019-03-01 → 2020-02-29d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥229.86 | 2018-03-01 → 2019-02-28d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥3,294.2 | at 2023-02-28 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥3,171.83 | at 2022-02-28 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥3,083.98 | at 2021-02-28d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥3,046.45 | at 2020-02-29d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,987.29 | at 2019-02-28d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 81.6% | at 2023-02-28 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 83.5% | at 2022-02-28 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 84.1% | at 2021-02-28d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 80.9% | at 2020-02-29d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 83.5% | at 2019-02-28d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 4.7% | 2022-03-01 → 2023-02-28 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 3.8% | 2021-03-01 → 2022-02-28 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 3.7% | 2020-03-01 → 2021-02-28d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.5% | 2019-03-01 → 2020-02-29d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.8% | 2018-03-01 → 2019-02-28d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 2,769 | at 2023-02-28 | Cons. | Number of employees |
| Employees | 2,784 | at 2022-02-28 | Cons. | Number of employees |
| Employees | 2,770 | at 2021-02-28d | Cons. | Number of employees |
| Employees | 2,745 | at 2020-02-29d | Cons. | Number of employees |
| Employees | 2,792 | at 2019-02-28d | Cons. | Number of employees |
| Revenue | ¥93.0bn | 2022-03-01 → 2023-02-28 | Standalone | Net sales |
| Revenue | ¥90.6bn | 2021-03-01 → 2022-02-28 | Standalone | Net sales |
| Revenue | ¥86.7bn | 2020-03-01 → 2021-02-28d | Standalone | Net sales (5-year summary) |
| Revenue | ¥109.8bn | 2019-03-01 → 2020-02-29d | Standalone | Net sales (5-year summary) |
| Revenue | ¥109.3bn | 2018-03-01 → 2019-02-28d | Standalone | Net sales (5-year summary) |
| Operating income | ¥10.8bn | 2022-03-01 → 2023-02-28 | Standalone | Operating income |
| Operating income | ¥8.6bn | 2021-03-01 → 2022-02-28 | Standalone | Operating income |
| Ordinary income | ¥14.1bn | 2022-03-01 → 2023-02-28 | Standalone | Ordinary income |
| Ordinary income | ¥10.6bn | 2021-03-01 → 2022-02-28 | Standalone | Ordinary income |
| Ordinary income | ¥10.4bn | 2020-03-01 → 2021-02-28d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥21.5bn | 2019-03-01 → 2020-02-29d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥19.9bn | 2018-03-01 → 2019-02-28d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥14.2bn | 2022-03-01 → 2023-02-28 | Standalone | Income before income taxes |
| Profit before tax | ¥9.9bn | 2021-03-01 → 2022-02-28 | Standalone | Income before income taxes |
| Net income | ¥10.4bn | 2022-03-01 → 2023-02-28 | Standalone | Profit loss |
| Net income | ¥7.2bn | 2021-03-01 → 2022-02-28 | Standalone | Profit loss |
| Net income | ¥8.3bn | 2020-03-01 → 2021-02-28d | Standalone | Net income loss (5-year summary) |
| Net income | ¥15.1bn | 2019-03-01 → 2020-02-29d | Standalone | Net income loss (5-year summary) |
| Net income | ¥15.9bn | 2018-03-01 → 2019-02-28d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥254.0bn | at 2023-02-28 | Standalone | Assets |
| Total assets | ¥254.3bn | at 2022-02-28 | Standalone | Assets |
| Total assets | ¥264.1bn | at 2021-02-28d | Standalone | Total assets (5-year summary) |
| Total assets | ¥266.1bn | at 2020-02-29d | Standalone | Total assets (5-year summary) |
| Total assets | ¥258.5bn | at 2019-02-28d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥39.5bn | at 2023-02-28 | Standalone | Liabilities |
| Total liabilities | ¥32.0bn | at 2022-02-28 | Standalone | Liabilities |
| Net assets / equity | ¥214.5bn | at 2023-02-28 | Standalone | Net assets |
| Net assets / equity | ¥222.4bn | at 2022-02-28 | Standalone | Net assets |
| Net assets / equity | ¥231.2bn | at 2021-02-28d | Standalone | Net assets |
| Net assets / equity | ¥225.6bn | at 2020-02-29d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥226.7bn | at 2019-02-28d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥68.6bn | at 2023-02-28 | Standalone | Cash and deposits |
| Cash and deposits | ¥80.0bn | at 2022-02-28 | Standalone | Cash and deposits |
| EPS (basic) | ¥131.21 | 2022-03-01 → 2023-02-28 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥88.25 | 2021-03-01 → 2022-02-28 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥102.07 | 2020-03-01 → 2021-02-28d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥183.45 | 2019-03-01 → 2020-02-29d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥190.96 | 2018-03-01 → 2019-02-28d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥131.1 | 2022-03-01 → 2023-02-28 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥88.19 | 2021-03-01 → 2022-02-28 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥101.97 | 2020-03-01 → 2021-02-28d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥183.23 | 2019-03-01 → 2020-02-29d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥190.77 | 2018-03-01 → 2019-02-28d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥84.5 | 2022-03-01 → 2023-02-28 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥84 | 2021-03-01 → 2022-02-28 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥83.5 | 2020-03-01 → 2021-02-28d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥83 | 2019-03-01 → 2020-02-29d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥82.5 | 2018-03-01 → 2019-02-28d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥2,754.67 | at 2023-02-28 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,784.39 | at 2022-02-28 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,825.43 | at 2021-02-28d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,755.32 | at 2020-02-29d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,737.34 | at 2019-02-28d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 84.3% | at 2023-02-28 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 87.3% | at 2022-02-28 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 87.5% | at 2021-02-28d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 84.6% | at 2020-02-29d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 87.6% | at 2019-02-28d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 4.8% | 2022-03-01 → 2023-02-28 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 3.2% | 2021-03-01 → 2022-02-28 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 3.7% | 2020-03-01 → 2021-02-28d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.7% | 2019-03-01 → 2020-02-29d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.1% | 2018-03-01 → 2019-02-28d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 85,164,895 | at 2023-02-28 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 85,164,895 | at 2022-02-28 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 85,164,895 | at 2021-02-28d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 85,164,895 | at 2020-02-29d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 95,164,895 | at 2019-02-28d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 1,521 | at 2023-02-28 | Standalone | Number of employees |
| Employees | 1,587 | at 2022-02-28 | Standalone | Number of employees |
| Employees | 1,583 | at 2021-02-28d | Standalone | Number of employees |
| Employees | 1,569 | at 2020-02-29d | Standalone | Number of employees |
| Employees | 1,596 | at 2019-02-28d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 2
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2023-02-28 | 58 pure |
| Pharmaceutical Businessreportable segment | employees | at 2023-02-28 | 2711 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,956
| Item | Context | Value | Unit |
|---|---|---|---|
| Purpose of shareholding quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row55Member | Original text (Japanese)取引関係の維持・強化を図るため。 | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row55Member | Original text (Japanese)有 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row56Member | Original text (Japanese)㈱りそなホールディングス | |
| Purpose of shareholding quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row56Member | Original text (Japanese)取引銀行として関係の強化を図るため。 | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row56Member | Original text (Japanese)有 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row57Member | Original text (Japanese)ソニーグループ㈱ | |
| Purpose of shareholding quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row57Member | Original text (Japanese)事業上の関係を強化し、企業価値向上を図るため。 | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row57Member | Original text (Japanese)無 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row58Member | Original text (Japanese)塩野義製薬㈱ | |
| Purpose of shareholding quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row58Member | Original text (Japanese)事業上の関係を強化し、企業価値向上を図るため。 | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row58Member | Original text (Japanese)無 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row59Member | Original text (Japanese)アルテック㈱ | |
| Number of shares not disclosed as below threshold details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row59Member | * | |
| Purpose of shareholding quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row59Member | Original text (Japanese)事業上の関係を強化し、企業価値向上を図るため。 | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row59Member | Original text (Japanese)無 | |
| Carrying amount not disclosed as below threshold details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row59Member | * | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row60Member | Original text (Japanese)中外製薬㈱ | |
| Purpose of shareholding quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row60Member | Original text (Japanese)事業上の関係を強化し、企業価値向上を図るため。 | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row60Member | Original text (Japanese)無 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row61Member | Original text (Japanese)フォスター電機㈱ | |
| Purpose of shareholding quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row61Member | Original text (Japanese)事業上の関係を強化し、企業価値向上を図るため。 | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row61Member | Original text (Japanese)有 | |
| Regulations in accordance with which consolidated financial statements have been prepared financial information | CurrentYearDuration | Text · Plus | |
| Regulations in accordance with which financial statements have been prepared financial information | CurrentYearDuration | Text · Plus | |
| Description of fact that financial statements have been prepared in accordance with special provision financial information | CurrentYearDuration | Original text (Japanese)また、当社は、特例財務諸表提出会社に該当し、財務諸表等規則第127条の規定により財務諸表を作成しています。 | |
| Note on independent audit financial information | CurrentYearDuration | Text · Plus | |
| Remarkable efforts to ensure fair presentation of consolidated financial statements etc financial information | CurrentYearDuration | Text · Plus | |
| Consolidated balance sheet (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of income (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of comprehensive income (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of changes in equity (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of cash flows (text) | CurrentYearDuration | Text · Plus | |
| Notes significant accounting policies for preparation of consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Number of consolidated subsidiaries and names of major consolidated subsidiaries (text) | CurrentYearDuration | Text · Plus | |
| Number of unconsolidated subsidiaries and associates accounted for using equity method and names of major entities accounted for using equity method (text) | CurrentYearDuration | Text · Plus | |
| Disclosure about fiscal years etc of consolidated subsidiaries (text) | CurrentYearDuration | Text · Plus | |
| Disclosure of accounting policies (text) | CurrentYearDuration | Text · Plus | |
| Notes changes in accounting policies in accordance with changes in accounting standards etc consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes new accounting standards not yet applied consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding amounts of notes and accounts receivable trade and contract assets (text) | CurrentYearInstant | Text · Plus | |
| Notes regarding shares and bonds etc of unconsolidated subsidiaries and associates (text) | CurrentYearInstant | Text · Plus | |
| Notes regarding pledged assets (text) | CurrentYearInstant | Text · Plus | |
| Notes regarding amounts of reduction entry of property plant and equipment (text) | CurrentYearInstant | Text · Plus | |
| Notes regarding revaluation of land for business (text) | CurrentYearInstant | Text · Plus | |
| Notes regarding amount of revenue from contracts with customers (text) | CurrentYearDuration | Text · Plus | |
| Major components of selling general and administrative expenses (text) | CurrentYearDuration | Text · Plus | |
| Research and development expenses included in general and administrative expenses and manufacturing cost for current period (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding cost of sales (text) | CurrentYearDuration | Text · Plus | |
| Gain on disposal of non current assets (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding loss on disposal of non current assets (text) | CurrentYearDuration | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |